×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by James R. Kasinger


Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 20, 2026Option/RSU Exercise-6,250-97,490Mar 24, 2026, 05:38 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 23, 2026Sale$46.783,182148,85494,308Mar 24, 2026, 05:38 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 16, 2026Sale$48.263,450166,49791,240Mar 17, 2026, 05:35 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 14, 2026Option/RSU Exercise-6,875-94,690Mar 17, 2026, 05:35 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 10, 2026Option/RSU Exercise-5,500-90,615Mar 12, 2026, 05:35 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 11, 2026Sale$52.802,800147,84087,815Mar 12, 2026, 05:35 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryFeb 18, 2026Option/RSU Exercise-3,825-87,227Feb 20, 2026, 05:35 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryFeb 19, 2026Sale$52.582,112111,04985,115Feb 20, 2026, 05:35 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryOct 13, 2025Option/RSU Exercise-2,114-84,478Oct 15, 2025, 05:35 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryOct 14, 2025Sale$66.601,07671,66283,402Oct 15, 2025, 05:35 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 20, 2025Option/RSU Exercise-6,250-84,914Mar 24, 2025, 05:35 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 21, 2025Sale$41.233,185131,31881,729Mar 24, 2025, 05:35 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 11, 2025Sale$42.422,850120,89777,530Mar 12, 2025, 07:05 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 12, 2025Sale$43.321,11648,34578,664Mar 12, 2025, 07:05 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 10, 2025Option/RSU Exercise-5,500-80,380Mar 12, 2025, 07:05 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 11, 2025Option/RSU Exercise-2,250-79,780Mar 12, 2025, 07:05 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryFeb 18, 2025Option/RSU Exercise-3,825-76,827Feb 19, 2025, 05:35 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryFeb 18, 2025Sale$53.859,595516,69173,002Feb 19, 2025, 05:35 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryFeb 19, 2025Sale$52.801,947102,80274,880Feb 19, 2025, 05:35 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryFeb 16, 2025Option/RSU Exercise-20,000-82,597Feb 19, 2025, 05:35 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryOct 13, 2024Option/RSU Exercise-2,113-63,686Oct 15, 2024, 06:00 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryOct 14, 2024Sale$46.281,08950,39962,597Oct 15, 2024, 06:00 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 11, 2024Sale$78.262,801219,20660,070Mar 12, 2024, 05:45 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 12, 2024Sale$74.441,14685,30861,174Mar 12, 2024, 05:45 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 10, 2024Option/RSU Exercise-5,500-62,871Mar 12, 2024, 05:45 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 11, 2024Option/RSU Exercise-2,250-62,320Mar 12, 2024, 05:45 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryFeb 18, 2024Option/RSU Exercise-3,825-59,284Feb 21, 2024, 05:45 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryFeb 20, 2024Sale$79.671,913152,40957,371Feb 21, 2024, 05:45 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 11, 2023Option/RSU Exercise-2,250-55,866Mar 14, 2023, 05:45 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 13, 2023Tax Payment (Shares)$43.222,30599,62254,844Mar 14, 2023, 05:45 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 10, 2023Option/RSU Exercise-2,833-54,899Mar 14, 2023, 05:45 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryFeb 18, 2023Option/RSU Exercise-3,825-54,016Feb 22, 2023, 05:35 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryFeb 21, 2023Tax Payment (Shares)$48.261,95094,10752,066Feb 22, 2023, 05:35 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryDec 03, 2022Option/RSU Exercise-6,667-53,425Dec 06, 2022, 05:47 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryDec 05, 2022Tax Payment (Shares)$52.263,234169,00950,191Dec 06, 2022, 05:47 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 10, 2022Option/RSU Exercise-2,834-46,539Mar 14, 2022, 06:01 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 11, 2022Tax Payment (Shares)$62.561,32182,64245,218Mar 14, 2022, 06:01 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 11, 2022Option/RSU Exercise-2,250-47,468Mar 14, 2022, 06:01 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 14, 2022Tax Payment (Shares)$61.081,03963,46246,429Mar 14, 2022, 06:01 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryDec 06, 2021Tax Payment (Shares)$69.176,303435,97843,542Dec 07, 2021, 08:00 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryDec 03, 2021Option/RSU Exercise-13,333-49,845Dec 07, 2021, 08:00 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryDec 02, 2021Option/RSU Exercise$13.627,34299,99836,512Dec 03, 2021, 08:00 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretarySep 10, 2021Option/RSU Exercise-10,000-33,911Sep 14, 2021, 09:45 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretarySep 13, 2021Tax Payment (Shares)$117.864,741558,77429,170Sep 14, 2021, 09:45 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 10, 2021Tax Payment (Shares)$124.151,353167,97523,911Mar 12, 2021, 05:43 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryMar 10, 2021Option/RSU Exercise-2,833-25,264Mar 12, 2021, 05:43 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryJan 19, 2021Option/RSU Exercise$51.4927,5001,415,97549,931Jan 20, 2021, 06:05 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryJan 19, 2021Sale$204.9427,5005,635,94443,146Jan 20, 2021, 06:05 PM
CRSPCRISPR Therapeutics AGJames R. KasingerGeneral Counsel and SecretaryDec 09, 2020Option/RSU Exercise$13.6222,026299,99422,415Dec 10, 2020, 04:35 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe